These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 28094017)

  • 1. Predictive Markers Guide Differentiation to Improve Graft Outcome in Clinical Translation of hESC-Based Therapy for Parkinson's Disease.
    Kirkeby A; Nolbrant S; Tiklova K; Heuer A; Kee N; Cardoso T; Ottosson DR; Lelos MJ; Rifes P; Dunnett SB; Grealish S; Perlmann T; Parmar M
    Cell Stem Cell; 2017 Jan; 20(1):135-148. PubMed ID: 28094017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying secreted biomarkers of dopaminergic ventral midbrain progenitor cells.
    Rifes P; Isaksson M; Rusimbi C; Ramón Santonja A; Nelander J; Laurell T; Kirkeby A
    Stem Cell Res Ther; 2023 Dec; 14(1):354. PubMed ID: 38072935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cryopreserved clinical-grade human embryonic stem cell-derived dopaminergic progenitors function in Parkinson's disease models.
    Naderi S; Shiri Z; Zarei-Kheirabadi M; Mollamohammadi S; Hosseini P; Rahimi G; Moradmand A; Samadian A; Shojaei A; Yeganeh M; Mousavi SA; Badri M; Taei A; Hassani SN; Baharvand H
    Life Sci; 2023 Sep; 329():121990. PubMed ID: 37524159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying the optimal developmental age of human pluripotent stem cell-derived midbrain dopaminergic progenitors for transplantation in a rodent model of Parkinson's disease.
    de Luzy IR; Pavan C; Moriarty N; Hunt CPJ; Vandenhoven Z; Khanna A; Niclis JC; Gantner CW; Thompson LH; Parish CL
    Exp Neurol; 2022 Dec; 358():114219. PubMed ID: 36055392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel two-factor monosynaptic TRIO tracing method for assessment of circuit integration of hESC-derived dopamine transplants.
    Aldrin-Kirk P; Åkerblom M; Cardoso T; Nolbrant S; Adler AF; Liu X; Heuer A; Davidsson M; Parmar M; Björklund T
    Stem Cell Reports; 2022 Jan; 17(1):159-172. PubMed ID: 34971563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical and dose-ranging assessment of hESC-derived dopaminergic progenitors for a clinical trial on Parkinson's disease.
    Park S; Park CW; Eom JH; Jo MY; Hur HJ; Choi SK; Lee JS; Nam ST; Jo KS; Oh YW; Lee J; Kim S; Kim DH; Park CY; Kim SJ; Lee HY; Cho MS; Kim DS; Kim DW
    Cell Stem Cell; 2024 Jan; 31(1):25-38.e8. PubMed ID: 38086390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IAP-Based Cell Sorting Results in Homogeneous Transplantable Dopaminergic Precursor Cells Derived from Human Pluripotent Stem Cells.
    Lehnen D; Barral S; Cardoso T; Grealish S; Heuer A; Smiyakin A; Kirkeby A; Kollet J; Cremer H; Parmar M; Bosio A; Knöbel S
    Stem Cell Reports; 2017 Oct; 9(4):1207-1220. PubMed ID: 28943253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of Novel Cell Surface Markers for Purification of Embryonic Dopamine Progenitors for Transplantation in Parkinson's Disease Animal Models.
    Fathi A; Mirzaei M; Dolatyar B; Sharifitabar M; Bayat M; Shahbazi E; Lee J; Javan M; Zhang SC; Gupta V; Lee B; Haynes PA; Baharvand H; Salekdeh GH
    Mol Cell Proteomics; 2018 Sep; 17(9):1670-1684. PubMed ID: 29848781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human midbrain dopaminergic neuronal differentiation markers predict cell therapy outcomes in a Parkinson's disease model.
    Xu P; He H; Gao Q; Zhou Y; Wu Z; Zhang X; Sun L; Hu G; Guan Q; You Z; Zhang X; Zheng W; Xiong M; Chen Y
    J Clin Invest; 2022 Jul; 132(14):. PubMed ID: 35700056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin C-Induced Epigenetic Modifications in Donor NSCs Establish Midbrain Marker Expressions Critical for Cell-Based Therapy in Parkinson's Disease.
    Wulansari N; Kim EH; Sulistio YA; Rhee YH; Song JJ; Lee SH
    Stem Cell Reports; 2017 Oct; 9(4):1192-1206. PubMed ID: 28943252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient generation of A9 midbrain dopaminergic neurons by lentiviral delivery of LMX1A in human embryonic stem cells and induced pluripotent stem cells.
    Sánchez-Danés A; Consiglio A; Richaud Y; Rodríguez-Pizà I; Dehay B; Edel M; Bové J; Memo M; Vila M; Raya A; Izpisua Belmonte JC
    Hum Gene Ther; 2012 Jan; 23(1):56-69. PubMed ID: 21877920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptome analysis reveals transmembrane targets on transplantable midbrain dopamine progenitors.
    Bye CR; Jönsson ME; Björklund A; Parish CL; Thompson LH
    Proc Natl Acad Sci U S A; 2015 Apr; 112(15):E1946-55. PubMed ID: 25775569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-Cell Analysis Reveals a Close Relationship between Differentiating Dopamine and Subthalamic Nucleus Neuronal Lineages.
    Kee N; Volakakis N; Kirkeby A; Dahl L; Storvall H; Nolbrant S; Lahti L; Björklund ÅK; Gillberg L; Joodmardi E; Sandberg R; Parmar M; Perlmann T
    Cell Stem Cell; 2017 Jan; 20(1):29-40. PubMed ID: 28094018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lineage tracing of stem cell-derived dopamine grafts in a Parkinson's model reveals shared origin of all graft-derived cells.
    Storm P; Zhang Y; Nilsson F; Fiorenzano A; Krausse N; Åkerblom M; Davidsson M; Yuan J; Kirkeby A; Björklund T; Parmar M
    Sci Adv; 2024 Oct; 10(42):eadn3057. PubMed ID: 39423273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immature Midbrain Dopaminergic Neurons Derived from Floor-Plate Method Improve Cell Transplantation Therapy Efficacy for Parkinson's Disease.
    Qiu L; Liao MC; Chen AK; Wei S; Xie S; Reuveny S; Zhou ZD; Hunziker W; Tan EK; Oh SKW; Zeng L
    Stem Cells Transl Med; 2017 Sep; 6(9):1803-1814. PubMed ID: 28650520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation, characterization, and banking of clinical-grade cells for neural transplantation: Scale up, fingerprinting, and genomic stability of stem cell lines.
    Natalwala A; Kunath T
    Prog Brain Res; 2017; 230():133-150. PubMed ID: 28552226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct efficacy of pre-differentiated versus intact fetal mesencephalon-derived human neural progenitor cells in alleviating rat model of Parkinson's disease.
    Wang X; Lu Y; Zhang H; Wang K; He Q; Wang Y; Liu X; Li L; Wang X
    Int J Dev Neurosci; 2004 Jun; 22(4):175-83. PubMed ID: 15245752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification of functional human ES and iPSC-derived midbrain dopaminergic progenitors using LRTM1.
    Samata B; Doi D; Nishimura K; Kikuchi T; Watanabe A; Sakamoto Y; Kakuta J; Ono Y; Takahashi J
    Nat Commun; 2016 Oct; 7():13097. PubMed ID: 27739432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategies for bringing stem cell-derived dopamine neurons to the clinic: A European approach (STEM-PD).
    Kirkeby A; Parmar M; Barker RA
    Prog Brain Res; 2017; 230():165-190. PubMed ID: 28552228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seq-ing Markers of Midbrain Dopamine Neurons.
    Osborn T; Hallett PJ
    Cell Stem Cell; 2017 Jan; 20(1):11-12. PubMed ID: 28061349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.